- Home
- ABOS vs BUUU Comparison
ABOS vs BUUU Comparison
Compare ABOS & BUUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- BUUU
- Stock Information
- Founded
- ABOS 1996
- BUUU 2017
- Country
- ABOS United States
- BUUU Hong Kong
- Employees
- ABOS N/A
- BUUU N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- BUUU Services-Misc. Amusement & Recreation
- Sector
- ABOS Health Care
- BUUU Consumer Discretionary
- Exchange
- ABOS Nasdaq
- BUUU Nasdaq
- Market Cap
- ABOS 84.2M
- BUUU 68.1M
- IPO Year
- ABOS 2021
- BUUU 2025
- Fundamental
- Price
- ABOS $1.44
- BUUU $6.13
- Analyst Decision
- ABOS Strong Buy
- BUUU
- Analyst Count
- ABOS 3
- BUUU 0
- Target Price
- ABOS $8.00
- BUUU N/A
- AVG Volume (30 Days)
- ABOS 211.5K
- BUUU 251.4K
- Earning Date
- ABOS 08-12-2025
- BUUU 01-01-0001
- Dividend Yield
- ABOS N/A
- BUUU N/A
- EPS Growth
- ABOS N/A
- BUUU N/A
- EPS
- ABOS N/A
- BUUU 0.04
- Revenue
- ABOS N/A
- BUUU $5,754,120.00
- Revenue This Year
- ABOS N/A
- BUUU N/A
- Revenue Next Year
- ABOS N/A
- BUUU N/A
- P/E Ratio
- ABOS N/A
- BUUU $138.21
- Revenue Growth
- ABOS N/A
- BUUU 64.23
- 52 Week Low
- ABOS $0.86
- BUUU $3.67
- 52 Week High
- ABOS $3.36
- BUUU $7.80
- Technical
- Relative Strength Index (RSI)
- ABOS 53.39
- BUUU N/A
- Support Level
- ABOS $1.34
- BUUU N/A
- Resistance Level
- ABOS $1.47
- BUUU N/A
- Average True Range (ATR)
- ABOS 0.08
- BUUU 0.00
- MACD
- ABOS 0.00
- BUUU 0.00
- Stochastic Oscillator
- ABOS 46.67
- BUUU 0.00
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.